Sleep quality improves during treatment with repetitive transcranial magnetic stimulation (rTMS) in patients with cocaine use disorder: a retrospective observational study
Open Access
- 6 April 2020
- journal article
- research article
- Published by Springer Nature in BMC Psychiatry
- Vol. 20 (1) , 1-12
Abstract
Background: Sleep disturbance is a prominent and common complaint in people with cocaine use disorder (CUD), either during intake or withdrawal. Repetitive transcranial magnetic stimulation (rTMS) has shown promise as a treatment for CUD. Thus, we evaluated the relationship between self-perceived sleep quality and cocaine use pattern variables in outpatients with CUD undergoing an rTMS protocol targeted at the left dorsolateral prefrontal cortex.Methods: This is a retrospective observational study including 87 patients diagnosed with CUD according to the DSM-5 criteria. Scores in Pittsburgh Sleep Quality Index (PSQI), Cocaine Craving Questionnaire (CCQ), Beck Depression Inventory-II (BDI-II), Self-rating Anxiety Scale (SAS), and Symptoms checklist 90-Revised (outcome used: Global Severity Index, GSI) were recorded at baseline, and after 5, 30, 60, and 90 days of rTMS treatment. Cocaine use was assessed by self-report and regular urine screens.Results: Sleep disturbances (PSQI scores> 5) were common in patients at baseline (mean ± SD; PSQI score baseline: 9.24 ± 3.89; PSQI> 5 in 88.5% of patients). PSQI scores significantly improved after rTMS treatment (PSQI score Day 90: 6.12 ± 3.32). Significant and consistent improvements were also seen in craving and in negative-affect symptoms compared to baseline. Considering the lack of a control group, in order to help the conceptualization of the outcomes, we compared the results to a wait-list group (n = 10). No significant improvements were observed in the wait-list group in any of the outcome measures.Conclusions: The present findings support the therapeutic role of rTMS interventions for reducing cocaine use and accompanying symptoms such as sleep disturbance and negative-affect symptoms.Trial registration: ClinicalTrials.gov.NCT03733821.Keywords
This publication has 79 references indexed in Scilit:
- Efficacy of Repetitive Transcranial Magnetic Stimulation in the Treatment of Patients with Chronic Primary InsomniaCell Biochemistry and Biophysics, 2013
- Dorsolateral prefrontal transcranial magnetic stimulation in patients with major depression locally affects alpha power of REM sleepFrontiers in Human Neuroscience, 2013
- The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorderFrontiers in Human Neuroscience, 2013
- Combination of Modafinil and d-amphetamine for the Treatment of Cocaine Dependence: A Preliminary InvestigationFrontiers in Psychiatry, 2012
- Sleep Deprivation Amplifies Reactivity of Brain Reward Networks, Biasing the Appraisal of Positive Emotional ExperiencesThe Journal of Neuroscience, 2011
- Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substancesMedical Hypotheses, 2010
- Modafinil for the treatment of cocaine dependenceDrug and Alcohol Dependence, 2009
- Sleep Deprivation Decreases Binding of [11C]Raclopride to Dopamine D2/D3Receptors in the Human BrainThe Journal of Neuroscience, 2008
- TMS-Induced Cortical Potentiation during Wakefulness Locally Increases Slow Wave Activity during SleepPLOS ONE, 2007
- A Rating Instrument For Anxiety DisordersPsychosomatics, 1971